CD14 inhibition experiments allowed us to conclude that ENO1, unlike LPS, only activates the CD14-dependent TLR4 pathway of monocytes to induce an important inflammatory response in healthy subjects and in RA patients. The gene discussed is ENO1; the disease is rheumatoid arthritis.